Correction to: “Cardiovascular Safety of Romosozumab vs PTH Analogues for Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study” - Summary - MDSpire
To correct errors in in-text reference citations in the original article, specifically the removal of unsupported citations.
Key Findings:
The original text incorrectly included references that were not listed in the reference section, which could mislead readers.
The corrected sentence now accurately reflects the lack of established pathophysiologic pathways related to romosozumab's effects on the cardiovascular system, reinforcing the study's integrity.
Interpretation:
The correction clarifies the discussion on the cardiovascular effects of romosozumab, ensuring that all claims are supported by appropriate citations.
Limitations:
The erratum does not address any potential impacts of the citation errors on the study's conclusions, which is crucial for understanding the reliability of the findings.
Conclusion:
The article has been updated online to reflect these corrections, enhancing the accuracy of the published research.
